1
|
Wagle SR, Kovacevic B, Foster T, Ionescu CM, Jones M, Mikov M, Wise A, Mooranian A, Al-Salami H. Probucol-bile acid nanoparticles: a novel approach and promising solution to prevent cellular oxidative stress in sensorineural hearing loss. J Drug Target 2024; 32:737-755. [PMID: 38758361 DOI: 10.1080/1061186x.2024.2349111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2024] [Revised: 04/22/2024] [Accepted: 04/24/2024] [Indexed: 05/18/2024]
Abstract
The use of antioxidants could thus prove an effective medication to prevent or facilitate recovery from oxidative stress-induced sensorineural hearing loss (SNHL). One promising strategy to prevent SNHL is developing probucol (PB)-based nanoparticles using encapsulation technology and administering them to the inner ear via the established intratympanic route. The preclinical, clinical and epidemiological studies support that PB is a proven antioxidant that could effectively prevent oxidative stress in different study models. Such findings suggest its applicability in preventing oxidative stress within the inner ear and its associated neural cells. However, several hurdles, such as overcoming the blood-labyrinth barrier, ensuring sustained release, minimising systemic side effects and optimising targeted delivery in the intricate inner ear structures, must be overcome to efficiently deliver PB to the inner ear. This review explores the background and pathogenesis of hearing loss, the potential of PB in treating oxidative stress and its cellular mechanisms, and the obstacles linked to inner ear drug delivery for effectively introducing PB to the inner ear.
Collapse
Affiliation(s)
- Susbin Raj Wagle
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
| | - Bozica Kovacevic
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
| | - Thomas Foster
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
| | - Corina Mihaela Ionescu
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
| | - Melissa Jones
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
| | - Momir Mikov
- Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
| | | | - Armin Mooranian
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
- School of Pharmacy, University of Otago, Dunedin, Otago, New Zealand
| | - Hani Al-Salami
- The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
- Medical School, University of Western Australia, Perth, Western Australia, Australia
| |
Collapse
|
2
|
Zhu G, Azharuddin M, Pramanik B, Roberg K, Biswas SK, D’arcy P, Lu M, Kaur A, Chen A, Dhara AK, Chivu A, Zhuang Y, Baker A, Liu X, Fairen-Jimenez D, Mazumder B, Chen R, Kaminski CF, Kaminski Schierle GS, Hinkula J, Slater NKH, Patra HK. Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation. ACS APPLIED MATERIALS & INTERFACES 2023; 15:17485-17494. [PMID: 36976817 PMCID: PMC10103128 DOI: 10.1021/acsami.2c21586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 03/20/2023] [Indexed: 06/18/2023]
Abstract
Despite the enormous advancements in nanomedicine research, a limited number of nanoformulations are available on the market, and few have been translated to clinics. An easily scalable, sustainable, and cost-effective manufacturing strategy and long-term stability for storage are crucial for successful translation. Here, we report a system and method to instantly formulate NF achieved with a nanoscale polyelectrolyte coacervate-like system, consisting of anionic pseudopeptide poly(l-lysine isophthalamide) derivatives, polyethylenimine, and doxorubicin (Dox) via simple "mix-and-go" addition of precursor solutions in seconds. The coacervate-like nanosystem shows enhanced intracellular delivery of Dox to patient-derived multidrug-resistant (MDR) cells in 3D tumor spheroids. The results demonstrate the feasibility of an instant drug formulation using a coacervate-like nanosystem. We envisage that this technique can be widely utilized in the nanomedicine field to bypass the special requirement of large-scale production and elongated shelf life of nanomaterials.
Collapse
Affiliation(s)
- Geyunjian
H. Zhu
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Mohammad Azharuddin
- Department
of Biomedical and Clinical Sciences (BKV), Linkoping University, Linköping 58183, Sweden
| | - Bapan Pramanik
- Department
of Chemistry, Ben Gurion University of the
Negev, Be’er
Sheva 84105, Israel
| | - Karin Roberg
- Department
of Biomedical and Clinical Sciences (BKV), Linkoping University, Linköping 58183, Sweden
- Department
of Otorhinolaryngology in Linköping, Anaesthetics, Operations
and Specialty Surgery Center, Linköping
University Hospital, Region Östergötland, Linköping 58185, Sweden
| | - Sujoy Kumar Biswas
- AIMP
Laboratories, C86 Baishnabghata,
Patuli Township, Kolkata 700094, India
| | - Padraig D’arcy
- Department
of Biomedical and Clinical Sciences (BKV), Linkoping University, Linköping 58183, Sweden
| | - Meng Lu
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Apanpreet Kaur
- Department
of Chemical Engineering, Imperial College
London, South Kensington
Campus, London SW7 2AZ, United Kingdom
| | - Alexander Chen
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Ashis Kumar Dhara
- Department
of Electrical Engineering, National Institute
of Technology Durgapur, Durgapur 713209, West Bengal, India
| | - Alexandru Chivu
- Department
of Surgical Biotechnology, Division of Surgery and Interventional
Science, University College London, London NW3 2PF, United Kingdom
| | - Yunhui Zhuang
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Andrew Baker
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Xiewen Liu
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - David Fairen-Jimenez
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Bismoy Mazumder
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Rongjun Chen
- Department
of Chemical Engineering, Imperial College
London, South Kensington
Campus, London SW7 2AZ, United Kingdom
| | - Clemens F. Kaminski
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | | | - Jorma Hinkula
- Department
of Biomedical and Clinical Sciences (BKV), Linkoping University, Linköping 58183, Sweden
| | - Nigel K. H. Slater
- Department
of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, United
Kingdom
| | - Hirak K. Patra
- Department
of Surgical Biotechnology, Division of Surgery and Interventional
Science, University College London, London NW3 2PF, United Kingdom
| |
Collapse
|
3
|
Thakkar M, Islam MS, Railkar A, Mitra S. Antisolvent precipitative immobilization of micro and nanostructured griseofulvin on laboratory cultured diatom frustules for enhanced aqueous dissolution. Colloids Surf B Biointerfaces 2020; 196:111308. [PMID: 32784059 DOI: 10.1016/j.colsurfb.2020.111308] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 08/01/2020] [Accepted: 08/04/2020] [Indexed: 01/03/2023]
Abstract
We report for the first time an antisolvent synthesis of nanostructured hydrophobic drug formulation onto a natural diatom. The jewel of the sea, a marine diatom, which is enriched in silicon, was cultured and grown in the laboratory. Its frustules were isolated and purified. The polar functional group on its surface provided unique physical and chemical properties. Griseofulvin (GF), an antifungal drug was used as a model compound was precipitated onto and adsorbed onto hydrophilic diatom surface, while stabilizer hydroxypropyl methyl cellulose (HPMC) was used for restricting particle growth during the composite synthesis. This work demonstrates that the fine drug crystals incorporated onto the diatom silica surface. The structural and morphological properties of the drug was characterized by various techniques. The drug loading of the formulation was estimated to be 41 % by weight. The incorporation of micro/nano crystals on the diatom surface dramatically enhanced the dissolution rate, and lowered the time required for 50 % dissolution for pure drug from 240-58 min for the drug composite, and the time required for 80 % dissolution or T80 was found to be 180 min for the composite while the pure drug reached a maximum of 65 % in 300 min.
Collapse
Affiliation(s)
- Megha Thakkar
- Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, United States
| | - Mohammad Saiful Islam
- Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, United States
| | - Aditya Railkar
- Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, United States
| | - Somenath Mitra
- Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, United States.
| |
Collapse
|
4
|
Mašková E, Kubová K, Raimi-Abraham BT, Vllasaliu D, Vohlídalová E, Turánek J, Mašek J. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery. J Control Release 2020; 324:695-727. [PMID: 32479845 DOI: 10.1016/j.jconrel.2020.05.045] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 05/27/2020] [Accepted: 05/27/2020] [Indexed: 02/07/2023]
Abstract
Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional pharmaceutical excipient widely exploited in oral sustained drug release matrix systems. The choice of numerous viscosity grades and molecular weights available from different manufacturers provides a great variability in its physical-chemical properties and is a basis for its broad successful application in pharmaceutical research, development, and manufacturing. The excellent mucoadhesive properties of HPMC predetermine its use in oromucosal delivery systems including mucoadhesive tablets and films. HPMC also possesses desirable properties for formulating amorphous solid dispersions increasing the oral bioavailability of poorly soluble drugs. Printability and electrospinnability of HPMC are promising features for its application in 3D printed drug products and nanofiber-based drug delivery systems. Nanoparticle-based formulations are extensively explored as antigen and protein carriers for the formulation of oral vaccines, and oral delivery of biologicals including insulin, respectively. HPMC, being a traditional pharmaceutical excipient, has an irreplaceable role in the development of new pharmaceutical technologies, and new drug products leading to continuous manufacturing processes, and personalized medicine. This review firstly provides information on the physical-chemical properties of HPMC and a comprehensive overview of its application in traditional oral drug formulations. Secondly, this review focuses on the application of HPMC in modern pharmaceutical technologies including spray drying, hot-melt extrusion, 3D printing, nanoprecipitation and electrospinning leading to the formulation of printlets, nanoparticle-, microparticle-, and nanofiber-based delivery systems for oral and oromucosal application. Hypromellose is an excellent excipient for formulation of classical dosage forms and advanced drug delivery systems. New methods of hypromellose processing include spray draying, hot-melt extrusion, 3D printing, and electrospinning.
Collapse
Affiliation(s)
- Eliška Mašková
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Kateřina Kubová
- Faculty of Pharmacy, Masaryk University, Brno 625 00, Czech Republic
| | - Bahijja T Raimi-Abraham
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Driton Vllasaliu
- School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Eva Vohlídalová
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic
| | - Jaroslav Turánek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| | - Josef Mašek
- Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Hudcova 70, Brno 621 00, Czech Republic.
| |
Collapse
|
5
|
Ciro Y, Rojas J, Di Virgilio AL, Alhajj MJ, Carabali GA, Salamanca CH. Production, physicochemical characterization, and anticancer activity of methotrexate-loaded phytic acid-chitosan nanoparticles on HT-29 human colon adenocarcinoma cells. Carbohydr Polym 2020; 243:116436. [PMID: 32532389 DOI: 10.1016/j.carbpol.2020.116436] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Revised: 04/23/2020] [Accepted: 05/10/2020] [Indexed: 12/19/2022]
Abstract
Methotrexate-loaded phytic acid-chitosan nanoparticles were synthesized by ionic gelation assisted by high-intensity sonication. The nanoparticles were characterized by particle size, polydispersity index, zeta potential (ZP) and encapsulation efficiency. Their physical stability was evaluated at 4 °C and 40 °C, whereas the in-vitro methotrexate release was assessed at pH 7.4. The data were heuristically fit to first-order, Higuchi, Peppas-Sahlin and Korsmeyer-Peppas models of release kinetics. Anticancer activity was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay on HT-29 human colon adenocarcinoma cells. Physicochemical analysis showed that the nanoparticles presented positive ZP values, sizes less than <300 nm and low polydispersity, except for systems formed with low amplitude sonication. The nanoparticles exhibited an adequate physical stability and a capability to modify methotrexate release by a non-Fickian mechanism, resulting in a more pronounced cytotoxic effect than the free drug on HT-29 human colon adenocarcinoma cells.
Collapse
Affiliation(s)
- Yhor Ciro
- University of Antioquia, School of Pharmaceutical and Food Sciences, Department of Pharmacy, 67 Street No. 53 - 108, Medellin, 050010, Colombia.
| | - John Rojas
- University of Antioquia, School of Pharmaceutical and Food Sciences, Department of Pharmacy, 67 Street No. 53 - 108, Medellin, 050010, Colombia.
| | - Ana Laura Di Virgilio
- Centro de Química Inorgánica (CEQUINOR), Consejo Nacional de Investigaciones Científicas y Técnicas - Universidad Nacional de La Plata, Bv. 120 N 1465, La Plata, Argentina.
| | - Maria J Alhajj
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122 -135, Cali, 760035, Colombia.
| | - Gustavo A Carabali
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122 -135, Cali, 760035, Colombia.
| | - Constain H Salamanca
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122 -135, Cali, 760035, Colombia.
| |
Collapse
|
6
|
Ciro Y, Rojas J, Alhajj MJ, Carabali GA, Salamanca CH. Production and Characterization of Chitosan-Polyanion Nanoparticles by Polyelectrolyte Complexation Assisted by High-Intensity Sonication for the Modified Release of Methotrexate. Pharmaceuticals (Basel) 2020; 13:E11. [PMID: 31936208 PMCID: PMC7168905 DOI: 10.3390/ph13010011] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 01/03/2020] [Accepted: 01/05/2020] [Indexed: 01/01/2023] Open
Abstract
A promising strategy to improve the effectivity of anticancer treatment and decrease its side effects is to modulate drug release by using nanoparticulates (NPs) as carriers. In this study, methotrexate-loaded chitosan-polyanion nanoparticles were produced by polyelectrolyte complexation assisted by high-intensity sonication, using several anionic polymers, such as the sodium and potassium salts of poly(maleic acid-alt-ethylene) and poly(maleic acid-alt-octadecene), here named PAM-2 and PAM-18, respectively. Such NPs were analyzed and characterized according to particle size, polydispersity index, zeta potential and encapsulation efficiency. Likewise, their physical stability was tested at 4 °C and 40 °C in order to evaluate any change in the previously mentioned particle parameters. The in vitro methotrexate release was assessed at a pH of 7.4, which simulated physiological conditions, and the data were fitted to the heuristic models of order one, Higuchi, Peppas-Sahlin and Korsmeyer-Peppas. The results revealed that most of the MTX-chitosan-polyanion NPs have positive zeta potential values, sizes <280 nm and monodisperse populations, except for the NPs formed with PAM-18 polyanions. Further, the NPs showed adequate physical stability, preventing NP-NP aggregation. Likewise, these carriers modified the MTX release by an anomalous mechanism, where the NPs formed with PAM-2 polymer led to a release mechanism controlled by diffusion and relaxation, whereas the NPs formed with PAM-18 led to a mainly diffusion-controlled release mechanism.
Collapse
Affiliation(s)
- Yhors Ciro
- Department of Pharmacy, School of Pharmaceutical and Food Sciences, University of Antioquia, 67 Street No. 53-108, Medellín 050010, Colombia;
| | - John Rojas
- Department of Pharmacy, School of Pharmaceutical and Food Sciences, University of Antioquia, 67 Street No. 53-108, Medellín 050010, Colombia;
| | - Maria J. Alhajj
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122-135, Cali 760035, Colombia; (M.J.A.); (G.A.C.)
| | - Gustavo A. Carabali
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122-135, Cali 760035, Colombia; (M.J.A.); (G.A.C.)
| | - Constain H. Salamanca
- Laboratorio de Diseño y Formulación de Productos Químicos y Derivados, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Naturales, Universidad ICESI, Calle 18 No. 122-135, Cali 760035, Colombia; (M.J.A.); (G.A.C.)
| |
Collapse
|
7
|
Li Y, Kohane DS. Microparticles. Biomater Sci 2020. [DOI: 10.1016/b978-0-12-816137-1.00030-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
8
|
Salis A, Porcu EP, Gavini E, Fois GR, Icaro Cornaglia A, Rassu G, Diana M, Maestri M, Giunchedi P, Nikolakakis I. In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies. Expert Opin Drug Deliv 2017; 14:453-465. [PMID: 28276966 DOI: 10.1080/17425247.2017.1295036] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
BACKGROUND In situ forming biodegradable poly(ε-caprolactone) (PCL) microspheres (PCL-ISM) system was developed as a novel embolic agent for transarterial embolization (TAE) therapy of hepatocellular carcinoma (HCC). Ibuprofen sodium (Ibu-Na) was loaded on this platform to evaluate its potential for the treatment of post embolization syndrome. METHODS The influence of formulation parameters on the size/shape, encapsulation efficiency and drug release was investigated using mixture experimental design. Regression models were derived and used to optimize the formulation for particle size, encapsulation efficiency and drug release profile for TAE therapy. An ex vivo model using isolated rat livers was established to assess the in situ formation of microspheres. RESULTS All PCL-ISM components affected the studied properties and fitting indices of the regression models were high (Radj2 = 0.810 for size, 0.964 encapsulation efficiency, and 0.993 or 0.971 for drug release at 30 min or 48 h). The optimized composition was: PCL = 4%, NMP = 43.1%, oil = 48.9%, surfactant = 2% and drug = 2%. Ex vivo studies revealed that PCL-ISM was able to form microspheres in the hepatic arterial bed. CONCLUSIONS PCL-ISM system provides a novel tool for the treatment of HCC and post-embolization syndrome. It is capable of forming microspheres with desirable size and Ibu-Na release profile after injection into blood vessels.
Collapse
Affiliation(s)
- Andrea Salis
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Elena P Porcu
- b Department of Diagnostic, Pediatric, Clinical and Surgical Science , University of Pavia , Pavia , Italy
| | - Elisabetta Gavini
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Giulia R Fois
- c 'G. Minardi' Laboratory of Cognitive Neuroscience, Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Antonia Icaro Cornaglia
- d Department of Public Health, Experimental and Forensic Medicine, Unit of Histology , University of Pavia , Pavia , Italy
| | - Giovanna Rassu
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Marco Diana
- c 'G. Minardi' Laboratory of Cognitive Neuroscience, Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Marcello Maestri
- e Surgery 1, IRCCS Policlinico San Matteo Foundation and Department of Diagnostic, Pediatric, Clinical and Surgical Sciences , University of Pavia , Pavia , Italy
| | - Paolo Giunchedi
- a Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy
| | - Ioannis Nikolakakis
- f Department of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences , Aristotle University of Thessaloniki , Thessaloniki , Greece
| |
Collapse
|
9
|
Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential. Eur J Pharm Sci 2016; 92:98-109. [PMID: 27393341 DOI: 10.1016/j.ejps.2016.07.004] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 07/02/2016] [Accepted: 07/04/2016] [Indexed: 11/24/2022]
Abstract
pH-sensitive nanoparticles which release in a controlled fashion on the skin or dissolve in the hair follicle could significantly improve treatment effectiveness and make transfollicular drug delivery a success. Dexamethasone-loaded Eudragit® L 100 nanoparticles were prepared by nanoprecipitation from an organic drug-polymer solution. Their toxicity potential was assessed using isolated human fibroblasts. pH-dependent swelling and erosion kinetics of the nanoparticles were investigated by dynamic light scattering and viscosity measurements and its effect on drug release was assessed in vitro with Franz diffusion cells. Stable, 100-550nm-sized dexamethasone-loaded Eudragit® L 100 nanoparticles with drug loading capacity and entrapment efficiency as high as 8.3% and 85%, respectively, were obtained by using polyvinyl alcohol as a stabilizer and ethanol as organic solvent. The nanoparticles showed little or no toxicity on isolated normal human fibroblasts. Dexamethasone existed in the nanoparticles as solid solution or in amorphous form. The nanoparticles underwent extensive swelling and slow drug release in media with a low buffer capacity (as low as 10mM) and a higher pH or at a pH close to the dissolution pH of the polymer (pH6) and a higher buffer capacity. In 40mM buffer and above pH6.8, the nanoparticles eroded fast or dissolved completely and thus released the drug rapidly. pH-sensitive nanoparticles which potentially release in a controlled manner on the stratum corneum but dissolve in the hair follicle could be prepared.
Collapse
|
10
|
Morsi N, Ghorab D, Refai H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 2016; 506:57-67. [DOI: 10.1016/j.ijpharm.2016.04.021] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Revised: 04/11/2016] [Accepted: 04/12/2016] [Indexed: 11/15/2022]
|
11
|
Edible HPMC films with indomethacin/HPMCP microparticles in oral delivery for taste-masking. Macromol Res 2014. [DOI: 10.1007/s13233-014-2186-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
12
|
Continuous API-crystal coating via coacervation in a tubular reactor. Int J Pharm 2014; 475:198-207. [DOI: 10.1016/j.ijpharm.2014.08.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2014] [Revised: 08/04/2014] [Accepted: 08/05/2014] [Indexed: 11/22/2022]
|
13
|
João CFC, Vasconcelos JM, Silva JC, Borges JP. An overview of inverted colloidal crystal systems for tissue engineering. TISSUE ENGINEERING PART B-REVIEWS 2014; 20:437-54. [PMID: 24328724 DOI: 10.1089/ten.teb.2013.0402] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Scaffolding is at the heart of tissue engineering but the number of techniques available for turning biomaterials into scaffolds displaying the features required for a tissue engineering application is somewhat limited. Inverted colloidal crystals (ICCs) are inverse replicas of an ordered array of monodisperse colloidal particles, which organize themselves in packed long-range crystals. The literature on ICC systems has grown enormously in the past 20 years, driven by the need to find organized macroporous structures. Although replicating the structure of packed colloidal crystals (CCs) into solid structures has produced a wide range of advanced materials (e.g., photonic crystals, catalysts, and membranes) only in recent years have ICCs been evaluated as devices for medical/pharmaceutical and tissue engineering applications. The geometry, size, pore density, and interconnectivity are features of the scaffold that strongly affect the cell environment with consequences on cell adhesion, proliferation, and differentiation. ICC scaffolds are highly geometrically ordered structures with increased porosity and connectivity, which enhances oxygen and nutrient diffusion, providing optimum cellular development. In comparison to other types of scaffolds, ICCs have three major unique features: the isotropic three-dimensional environment, comprising highly uniform and size-controllable pores, and the presence of windows connecting adjacent pores. Thus far, this is the only technique that guarantees these features with a long-range order, between a few nanometers and thousands of micrometers. In this review, we present the current development status of ICC scaffolds for tissue engineering applications.
Collapse
Affiliation(s)
- Carlos Filipe C João
- 1 CENIMAT/I3N, Departamento de Ciência dos Materiais, Faculdade de Ciências e Tecnologia, FCT, Universidade Nova de Lisboa , Caparica, Portugal
| | | | | | | |
Collapse
|
14
|
Wang R, Tian M, Wang Y. Coacervation and aggregate transitions of a cationic ammonium gemini surfactant with sodium benzoate in aqueous solution. SOFT MATTER 2014; 10:1705-1713. [PMID: 24651935 DOI: 10.1039/c3sm52819g] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Coacervation in an aqueous solution of cationic ammonium gemini surfactant hexamethylene-1,6-bis(dodecyldimethylammonium bromide) (C12C6C12Br2) with sodium benzoate (NaBz) has been investigated at 25 °C by turbidity titration, light microscopy, dynamic light scattering, cryogenic temperature transmission electron microscopy (Cryo-TEM), scanning electron microscopy (SEM), isothermal titration calorimetry, ζ potential and (1)H NMR measurements. There is a critical NaBz concentration of 0.10 M, only above which coacervation can take place. However, if the NaBz concentration is too large, coacervation also becomes difficult. Coacervation takes place at a very low concentration of C12C6C12Br2 and exists in a very wide concentration region of C12C6C12Br2. The phase behavior in the NaBz concentration from 0.15 to 0.50 M includes spherical micelles, threadlike micelles, coacervation, and precipitation. With increasing NaBz concentration, the phase boundaries of coacervation shift to higher C12C6C12Br2 concentration. Moreover, the C12C6C12Br2-NaBz aggregates in the coacervate are found to be close to charge neutralized. The Cryo-TEM and SEM images of the coacervate shows a layer-layer stacking structure consisting of a three-dimensional network formed by the assembly of threadlike micelles. Long, dense and almost uncharged threadlike micelles are the precursors of coacervation in the system.
Collapse
Affiliation(s)
- Ruijuan Wang
- Key Laboratory of Colloid and Interface Science, Beijing National Laboratory for Molecular Sciences (BNLMS), Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
| | | | | |
Collapse
|
15
|
Hao S, Wang B, Wang Y, Zhu L, Wang B, Guo T. Preparation of Eudragit L 100-55 enteric nanoparticles by a novel emulsion diffusion method. Colloids Surf B Biointerfaces 2013; 108:127-33. [DOI: 10.1016/j.colsurfb.2013.02.036] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Revised: 02/21/2013] [Accepted: 02/22/2013] [Indexed: 10/27/2022]
|
16
|
Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction. JOURNAL OF PHARMACEUTICAL INVESTIGATION 2013. [DOI: 10.1007/s40005-013-0065-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
Hanafi A, Nograles N, Abdullah S, Shamsudin MN, Rosli R. Cellulose Acetate Phthalate Microencapsulation and Delivery of Plasmid DNA to the Intestines. J Pharm Sci 2013. [DOI: 10.1002/jps.23389] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
18
|
|
19
|
Yehia S, Elshafeey A, ElMeshad A, Al-Bialey H. Formulation and évaluation of itopride microcapsules in human volunteers. J Drug Deliv Sci Technol 2013. [DOI: 10.1016/s1773-2247(13)50036-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Thomas S, Chong YN, Chaw CS. Preparation and characterization of enteric microparticles by coacervation. Drug Dev Ind Pharm 2012; 39:1142-51. [DOI: 10.3109/03639045.2012.725734] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
21
|
Alhnan MA, Kidia E, Basit AW. Spray-drying enteric polymers from aqueous solutions: A novel, economic, and environmentally friendly approach to produce pH-responsive microparticles. Eur J Pharm Biopharm 2011; 79:432-9. [DOI: 10.1016/j.ejpb.2011.03.015] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2011] [Revised: 03/12/2011] [Accepted: 03/16/2011] [Indexed: 11/28/2022]
|
22
|
Rizi K, Green RJ, Khutoryanskaya O, Donaldson M, Williams AC. Mechanisms of burst release from pH-responsive polymeric microparticles. J Pharm Pharmacol 2011; 63:1141-55. [PMID: 21827486 DOI: 10.1111/j.2042-7158.2011.01322.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES Microencapsulation of drugs into preformed polymers is commonly achieved through solvent evaporation techniques or spray drying. We compared these encapsulation methods in terms of controlled drug release properties of prepared microparticles and investigated the underlying mechanisms responsible for the 'burst release' effect. METHODS Using two different pH-responsive polymers with a dissolution threshold of pH 6 (Eudragit L100 and AQOAT AS-MG), hydrocortisone, a model hydrophobic drug, was incorporated into microparticles below and above its solubility within the polymer matrix. KEY FINDINGS Although, spray drying was an attractive approach due to rapid particle production and relatively low solvent waste, the oil-in-oil microencapsulation method was superior in terms of controlled drug release properties from the microparticles. Slow solvent evaporation during the oil-in-oil emulsification process allowed adequate time for drug and polymer redistribution in the microparticles and reduced uncontrolled drug burst release. Electron microscopy showed that this slower manufacturing procedure generated nonporous particles whereas thermal analysis and X-ray diffractometry showed that drug loading above the solubility limit of the drug in the polymer generated excess crystalline drug on the surface of the particles. Raman spectral mapping illustrated that drug was homogeneously distributed as a solid solution in the particles when loaded below saturation in the polymer with consequently minimal burst release. CONCLUSIONS Both the manufacturing method (which influenced particle porosity and density) and drug:polymer compatibility and loading (which affected drug form and distribution) were responsible for burst release seen from our particles.
Collapse
Affiliation(s)
- Khalida Rizi
- Reading School of Pharmacy, University of Reading, Whiteknights, Reading, UK
| | | | | | | | | |
Collapse
|
23
|
Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloids Surf B Biointerfaces 2011; 84:163-71. [DOI: 10.1016/j.colsurfb.2010.12.031] [Citation(s) in RCA: 369] [Impact Index Per Article: 28.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2010] [Revised: 12/12/2010] [Accepted: 12/27/2010] [Indexed: 11/21/2022]
|
24
|
Rizi K, Green RJ, Donaldson M, Williams AC. Production of pH-Responsive Microparticles by Spray Drying: Investigation of Experimental Parameter Effects on Morphological and Release Properties. J Pharm Sci 2011; 100:566-79. [DOI: 10.1002/jps.22291] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2010] [Revised: 05/06/2010] [Accepted: 06/08/2010] [Indexed: 11/07/2022]
|
25
|
Al-Ghananeem AM, Abbassi M, Shrestha S, Raman G, Wulff H, Pereira L, Ansari A. Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant. Drug Dev Ind Pharm 2011; 36:563-9. [PMID: 19929567 DOI: 10.3109/03639040903329554] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Enteric microencapsulation of the potential immunosuppressant TRAM-34 was investigated as a means of enhancing oral drug delivery and minimizing or eliminating hydrolysis of pyrazole-substituted triarylmethane to the respective alcohol. METHOD TRAM-34 was successfully enteric microencapsulated by a coacervation method using the pH-sensitive Eudragit L 100 polymer. In this study, we utilized water-miscible organic solvents such as acetone and ethanol, which are considered safe class 3 solvents according to the ICH guideline. We deemed such an approach suitable for safe scale up and for enteric coating application to other compounds of a similar lipophilicity. RESULTS The resulting microparticles were spherical and uniform with an average particle size of 460 microm at 15% theoretical loading. The encapsulation efficiency was 90 +/- 1.9% and the percentage yield was found to be 91.5 +/- 0.3%. The oral administration in rhesus macaques of TRAM-34-loaded enteric-coated microparticles illustrated six times enhancement in its oral bioavailability. However, the TRAM-34 plasma concentration was less than the therapeutic effective level. CONCLUSION The low oral bioavailability, even after enteric coating, could be attributed to the compound's inherent absorption characteristics and high lipophilicity.
Collapse
Affiliation(s)
- Abeer M Al-Ghananeem
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
| | | | | | | | | | | | | |
Collapse
|
26
|
Tavera EM, Kadali SB, Bagaria HG, Liu AW, Wong MS. Experimental and modeling analysis of diffusive release from single-shell microcapsules. AIChE J 2009. [DOI: 10.1002/aic.11914] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
27
|
Rafati H, Talebpour Z, Adlnasab L, Ebrahimi SN. Quality by design: Optimization of a liquid filled pH-responsive macroparticles using Draper-Lin composite design. J Pharm Sci 2009; 98:2401-11. [DOI: 10.1002/jps.21625] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
28
|
Deng M, Cao M, Wang Y. Coacervation of Cationic Gemini Surfactant with Weakly Charged Anionic Polyacrylamide. J Phys Chem B 2009; 113:9436-40. [DOI: 10.1021/jp903326w] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Manli Deng
- Key Laboratory of Colloid and Interface Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China
| | - Meiwen Cao
- Key Laboratory of Colloid and Interface Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China
| | - Yilin Wang
- Key Laboratory of Colloid and Interface Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China
| |
Collapse
|
29
|
Oana H, Kishimura A, Yonehara K, Yamasaki Y, Washizu M, Kataoka K. Spontaneous Formation of Giant Unilamellar Vesicles from Microdroplets of a Polyion Complex by Thermally Induced Phase Separation. Angew Chem Int Ed Engl 2009; 48:4613-6. [DOI: 10.1002/anie.200900721] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
30
|
Oana H, Kishimura A, Yonehara K, Yamasaki Y, Washizu M, Kataoka K. Spontaneous Formation of Giant Unilamellar Vesicles from Microdroplets of a Polyion Complex by Thermally Induced Phase Separation. Angew Chem Int Ed Engl 2009. [DOI: 10.1002/ange.200900721] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
31
|
Hammady T, El-Gindy A, Lejmi E, Dhanikula R, Moreau P, Hildgen P. Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models. Int J Pharm 2009; 369:185-95. [DOI: 10.1016/j.ijpharm.2008.10.034] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2008] [Revised: 10/21/2008] [Accepted: 10/28/2008] [Indexed: 10/21/2022]
|
32
|
Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B, Gupta V, Ma C, Mahajan N, Akrami A, Surapaneni S. Enhanced Bioavailability of a Poorly Soluble VR1 Antagonist Using an Amorphous Solid Dispersion Approach: A Case Study. Mol Pharm 2008; 5:981-93. [DOI: 10.1021/mp800061r] [Citation(s) in RCA: 114] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Michael Kennedy
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Jack Hu
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Ping Gao
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Lan Li
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Alana Ali-Reynolds
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Ben Chal
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Vicki Gupta
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Chandra Ma
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Nidhi Mahajan
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Anna Akrami
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| | - Sekhar Surapaneni
- Small Molecule Process & Product Development, Amgen Inc., Thousand Oaks, California 91320, and Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320
| |
Collapse
|